Antimicrobial and Antibiofilm Potential of Injectable Platelet Rich Fibrin-a Second-generation Platelet Concentrate-against Biofilm Producing Oral Staphylococcus Isolates

Overview

Journal Saudi J Biol Sci

Specialty Biology

Date 2020 Jan 1

PMID 31889815

Citations 26

Authors

Sharmila Jasmine

Thangavelu A

K Janarthanan

Rajapandiyan Krishnamoorthy

Ali A Alshatwi

Affiliations

Soon will be listed here.

Abstract

Injectable Platelet rich fibrin (i-PRF) is a platelet concentrate that has been extensively used for multiple medical purposes and is a valuable adjunct for the regeneration of damaged tissues in surgical procedures. The enriched bioactive substances in i-PRF are responsible for speeding the wound healing process. Infection of biofilm producing bacteria in surgical wounds is becoming a serious threat. Research in this field is focused on new strategies to fight infections and to reduce the healing time. The present study was aimed to evaluate the in vitro antimicrobial and antibiofilm effects of i-PRF against oral pathogenic biofilm producing staphylococcus bacteria isolated from patient with dental and oral abscess. The antibacterial activity of i-PRF, was determined through broth microdilution as minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC). i-PRF exhibited bactericidal activity against both non biofilm and biofilm producing bacteria. i-PRF could be potential antimicrobial peptide used to combat postoperative infections caused by biofilm producing staphylococcus.

Citing Articles

Application of injectable platelet-rich fibrin (I-PRF) after posterior tooth removal surgery: a systematic review.

de Santana I, Viana M, Dias J, Ferreira A, SantAna E, Ribeiro E Cell Tissue Bank. 2025; 26(2):12.

PMID: 40014206 DOI: 10.1007/s10561-025-10160-9.

Platelet-rich fibrin obtained from different protocols affects the formation of the multispecies subgingival biofilm associated with periodontitis.

Uyeda F, Quilles Vargas G, Matias Malavazi L, Macedo T, Gomes A, Bueno M J Oral Microbiol. 2025; 17(1):2445598.

PMID: 39801747 PMC: 11722119. DOI: 10.1080/20002297.2024.2445598.

The effect of injectable platelet-rich fibrin in combination with autogenous bone grafts on bone healing in an ovariectomized osteoporotic rat model with critical-sized defects.

Durmuslar M, Gulsen E, Bayburt K, Balli U, Ocak M, Firat A Saudi Med J. 2024; 45(8):791-798.

PMID: 39074896 PMC: 11288487. DOI: 10.15537/smj.2024.45.8.20240224.

How to explain the beneficial effects of leukocyte- and platelet-rich fibrin.

Blanco J, Garcia A, Garcia Alonso A, Hermida-Nogueira L, Castro A Periodontol 2000. 2024; 97(1):74-94.

PMID: 38923566 PMC: 11808445. DOI: 10.1111/prd.12570.

Injectable Platelet-Rich Fibrin and Advanced Platelet-Rich Fibrin Demonstrate Enhanced Anti-Biofilm Effect Compared to Enamel Matrix Derivatives on Decontaminated Titanium Surfaces.

Varghese J, Ramenzoni L, Shenoy P, Schmidlin P, Mehrotra S, Kamath V Dent J (Basel). 2024; 12(6).

PMID: 38920876 PMC: 11202555. DOI: 10.3390/dj12060175.

References

Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J . Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014; 40(6):679-89. DOI: 10.1563/aaid-joi-D-14-00138. View

Cieslik-Bielecka A, Bielecki T, Gazdzik T, Cieslik T, Szczepanski T . Improved treatment of mandibular odontogenic cysts with platelet-rich gel. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105(4):423-9. DOI: 10.1016/j.tripleo.2007.07.039. View

Krishnamoorthy R, Athinarayanan J, Periasamy V, Adisa A, Al-Shuniaber M, Gassem M . Antimicrobial activity of nanoemulsion on drug-resistant bacterial pathogens. Microb Pathog. 2018; 120:85-96. DOI: 10.1016/j.micpath.2018.04.035. View

Wolcott R, Rumbaugh K, James G, Schultz G, Phillips P, Yang Q . Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care. 2010; 19(8):320-8. DOI: 10.12968/jowc.2010.19.8.77709. View

Fabbro M, Bortolin M, Taschieri S, Ceci C, Weinstein R . Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence. Platelets. 2016; 27(4):276-85. DOI: 10.3109/09537104.2015.1116686. View

Liduma I, Tracevska T, Bers U, Zilevica A . Phenotypic and genetic analysis of biofilm formation by Staphylococcus epidermidis. Medicina (Kaunas). 2012; 48(6):305-9. View

Radek K, Gallo R . Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol. 2007; 29(1):27-43. DOI: 10.1007/s00281-007-0064-5. View

Moojen D, Everts P, Schure R, Overdevest E, van Zundert A, Knape J . Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2007; 26(3):404-10. DOI: 10.1002/jor.20519. View

Patanwala A, Erstad B, Nix D . Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections. Curr Med Res Opin. 2007; 23(1):185-93. DOI: 10.1185/030079906X162700. View

10.

Barasch A, Safford M, Litaker M, Gilbert G . Risk factors for oral postoperative infection in patients with diabetes. Spec Care Dentist. 2008; 28(4):159-66. DOI: 10.1111/j.1754-4505.2008.00035.x. View

11.

Gilbert P, Allison D, McBain A . Biofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?. J Appl Microbiol. 2002; 92 Suppl:98S-110S. View

12.

Mai-Prochnow A, Lucas-Elio P, Egan S, Thomas T, Webb J, Sanchez-Amat A . Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several gram-negative bacteria. J Bacteriol. 2008; 190(15):5493-501. PMC: 2493266. DOI: 10.1128/JB.00549-08. View

13.

Percival S, McCarty S, Lipsky B . Biofilms and Wounds: An Overview of the Evidence. Adv Wound Care (New Rochelle). 2015; 4(7):373-381. PMC: 4486148. DOI: 10.1089/wound.2014.0557. View

14.

Blair P, Flaumenhaft R . Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009; 23(4):177-89. PMC: 2720568. DOI: 10.1016/j.blre.2009.04.001. View

15.

Intravia J, Allen D, Durant T, McCarthy M, Russell R, Beitzel K . In vitro evaluation of the anti-bacterial effect of two preparations of platelet rich plasma compared with cefazolin and whole blood. Muscles Ligaments Tendons J. 2014; 4(1):79-84. PMC: 4049655. View

16.

Hurlow J, Couch K, Laforet K, Bolton L, Metcalf D, Bowler P . Clinical Biofilms: A Challenging Frontier in Wound Care. Adv Wound Care (New Rochelle). 2015; 4(5):295-301. PMC: 4432968. DOI: 10.1089/wound.2014.0567. View

17.

Kour P, Pudakalkatti P, Vas A, Das S, Padmanabhan S . Comparative Evaluation of Antimicrobial Efficacy of Platelet-rich Plasma, Platelet-rich Fibrin, and Injectable Platelet-rich Fibrin on the Standard Strains of and . Contemp Clin Dent. 2018; 9(Suppl 2):S325-S330. PMC: 6169270. DOI: 10.4103/ccd.ccd_367_18. View

18.

Paharik A, Horswill A . The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response. Microbiol Spectr. 2016; 4(2). PMC: 4887152. DOI: 10.1128/microbiolspec.VMBF-0022-2015. View

19.

Levy O . Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood. 2000; 96(8):2664-72. View

20.

Cieslik-Bielecka A, Reichert P, Skowronski R, Krolikowska A, Bielecki T . A new aspect of antimicrobial leukocyte- and platelet-rich plasma activity based on flow cytometry assessment. Platelets. 2018; 30(6):728-736. DOI: 10.1080/09537104.2018.1513472. View